Legal & General Group Plc Acquires Shares of 4,205,461 Danaher Corporation $DHR

Legal & General Group Plc bought a new position in shares of Danaher Corporation (NYSE:DHR) during the second quarter, Holdings Channel.com reports. The firm bought 4,205,461 shares of the conglomerate’s stock, valued at approximately $801,056,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Sivia Capital Partners LLC grew its stake in Danaher by 6.3% in the second quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock worth $397,000 after purchasing an additional 119 shares during the period. First Trust Advisors LP lifted its position in Danaher by 34.5% during the second quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate’s stock valued at $10,947,000 after buying an additional 14,217 shares during the period. Main Street Financial Solutions LLC lifted its position in Danaher by 40.2% during the second quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate’s stock valued at $610,000 after buying an additional 886 shares during the period. Ieq Capital LLC boosted its holdings in shares of Danaher by 64.2% during the 2nd quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate’s stock valued at $14,957,000 after buying an additional 29,592 shares in the last quarter. Finally, HUB Investment Partners LLC boosted its holdings in shares of Danaher by 30.7% during the 2nd quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate’s stock valued at $273,000 after buying an additional 325 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

DHR has been the subject of several research reports. Stifel Nicolaus decreased their price target on shares of Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. Weiss Ratings raised Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, July 15th. Royal Bank Of Canada lifted their price objective on Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a research note on Wednesday, July 22nd. Piper Sandler began coverage on Danaher in a report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 target price on the stock. Finally, Guggenheim cut their target price on Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $228.91.

Danaher Trading Down 1.7%

Shares of NYSE:DHR opened at $215.18 on Tuesday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The company has a market cap of $151.27 billion, a P/E ratio of 38.22, a PEG ratio of 2.72 and a beta of 0.78. The stock’s fifty day moving average price is $196.49 and its 200-day moving average price is $192.39. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. During the same quarter last year, the firm posted $0.77 EPS. The business’s quarterly revenue was up 5.5% compared to the same quarter last year. Sell-side analysts expect that Danaher Corporation will post 8.53 earnings per share for the current year.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.